Niagen Bioscience, Inc.
NAGE· Nasdaq
Filed Mar 15, 2012 · 10-K · 75 days after period end · 0001415889-12-000348
derived · Computed from the longer spans the company filed.
| Metric | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Niagen Bioscience, Inc. · CIK 1386570 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Mar 15, 2012 · 75 d after period end